Literature DB >> 10668450

Peroxynitrite scavengers for the acute treatment of traumatic brain injury.

E D Hall1, N C Kupina, J S Althaus.   

Abstract

Recent evidence has suggested that the superoxide and nitric oxide-derived reactive oxygen species peroxynitrite (ONOO-) may play a significant role in the acute pathophysiology of brain injury. One pharmacological mechanism by which ONOO(-)-mediated damage might be interrupted is by the administration of scavenging compounds such as the thiol-containing compound penicillamine. In the present study, we examined the ability of either penicillamine (Pen) or the more brain penetrable penicillamine methyl ester (PenME) (0.01, 0.1, 1.0 or 10.0 mg/kg i.v. 5 min post-injury) to improve the early (1 hr) neurological recovery (grip score) of male CF-1 mice after a severe (900 g-cm; 50 g x 18 cm) injury. Pen produced a dose-related improvement in grip score. At 1.0 mg/kg, a +112% improvement was observed compared to vehicle-treated mice, and at 10.0 mg/kg, the increase was +168% (both, p < 0.05). PenME more potently improved the 1-hr grip score, but the magnitude of the optimal effect (+96% at 0.1 mg/kg; p < 0.02) was no greater than that observed with Pen, which largely remains in the cerebral microvasculature. These results are consistent with a role of ONOO- in acute head injury, but suggest that microvascular scavenging may be of primary therapeutic importance during the early post-traumatic period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668450     DOI: 10.1111/j.1749-6632.1999.tb08025.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  23 in total

Review 1.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

Review 2.  Combination therapies for neurobehavioral and cognitive recovery after experimental traumatic brain injury: Is more better?

Authors:  Anthony E Kline; Jacob B Leary; Hannah L Radabaugh; Jeffrey P Cheng; Corina O Bondi
Journal:  Prog Neurobiol       Date:  2016-05-07       Impact factor: 11.685

Review 3.  Antioxidant therapies for traumatic brain injury.

Authors:  Edward D Hall; Radhika A Vaishnav; Ayman G Mustafa
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

4.  Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Anandakumar Shunmugavel; Tajinder S Dhammu; Hamza Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2018-07-19       Impact factor: 4.164

5.  Lipid peroxidation-derived reactive aldehydes directly and differentially impair spinal cord and brain mitochondrial function.

Authors:  Radhika A Vaishnav; Indrapal N Singh; Darren M Miller; Edward D Hall
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

6.  Simvastatin reduces VEGF and NO levels in acute stages of experimental traumatic brain injury.

Authors:  Hatice Yüksel; Özlem Yavuz; Merih Iş; Nil Çomunoğlu; Gülay Üzüm; Feyzullah Akyüz; Hayriye Ak Yıldırım
Journal:  Neurol Sci       Date:  2013-03-31       Impact factor: 3.307

Review 7.  Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.

Authors:  Robert J Delorenzo; David A Sun; Laxmikant S Deshpande
Journal:  Pharmacol Ther       Date:  2004-12-09       Impact factor: 12.310

8.  Tempol protection of spinal cord mitochondria from peroxynitrite-induced oxidative damage.

Authors:  Yiqin Xiong; Indrapal N Singh; Edward D Hall
Journal:  Free Radic Res       Date:  2009-06

9.  Co-activation of μ- and δ-opioid receptors elicits tolerance to morphine-induced ventilatory depression via generation of peroxynitrite.

Authors:  Alex P Young; Ryan B Gruber; Joe F Discala; Walter J May; Dylan McLaughlin; Lisa A Palmer; Stephen J Lewis
Journal:  Respir Physiol Neurobiol       Date:  2013-03-05       Impact factor: 1.931

Review 10.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.